Breast cancer: present and future

Áreas de cooperação: 
Pessoa de contato: 
Cristina Núñez González
Hospital Universitario Lucus Augusti
Rúa Ulises Romero Nº1
Código Postal: 
Palavras chave: 
breast cancer, luminal A, luminal B, HER2-positive, and triple negative
Descrição do projeto: 
Breast cancer (BC) is the most commonly diagnosed cancer in women worldwide. Today, even though major breast cancer subtypes have been characterized, i.e., luminal A, luminal B, HER2-positive, and triple negative, little is known about the heterogeneity of breast cancer in blood. In particular, phosphoproteins secreted or shed by cancer cells constitute a largely overlooked source of biomarker candidates that could be correlated with breast cancer subtypes and/or disease status.
Principais objetivos: 
The main objective of this proposal is discovering minimally invasive protein biomarkers in blood for the early noninvasive diagnosis, classification and monitorization of different breast cancer subtypes. These new blood-based biomarkers that are highly specific could offer the potential to decrease BC morbidity as well as identify the most appropriate treatment options.

Boletim Informativo

Seleccione abajo para suscribirse

POCTEP nos meios de comunicação

Ideias de projetos / procura de parceiros

Contatos POCTEP

Contatos  2014-2020 | Contatos 2007-2013

  • | (+34) 924 20 59 58
  • C/ Luís Álvarez Lencero 3, Planta 3ª, Of. 13, 06011 BADAJOZ (Espanha)